Elsevier

The Lancet

Volume 346, Issue 8966, 1 July 1995, Pages 12-17
The Lancet

Staging system for clinical AIDS patients

https://doi.org/10.1016/S0140-6736(95)92649-6Get rights and content

Abstract

Summary

Although there are wide differences in prognosis between patients with AIDS they are often thought of as a single homogeneous group. We think a simple staging system that accounts for important prognostic factors including type and number of AIDS diseases and the CD4 lymphocyte count is required.

We followed 363 AIDS patients at the Royal Free Hospital and reported the occurrence of 680 AIDS-defining diseases (ADDs). We measured CD4 counts at approximately monthly intervals. Severity of AIDS diseases was defined a priori on the basis of survival in the AIDS in Europe study of 6578 AIDS patients: mild—oesophageal candidiasis, Kaposis sarcoma (cutaneous), Pneumocystis carinii pneumonia, extrapulmonary tuberculosis; severe— all other ADDs except lymphoma; very severe—lymphoma. The risk of death increased by 15% (p=0·08) for each mild condition experienced, by 89% (p<0·0001) for each new severe condition and by 535% (p<0·0001) when a lymphoma developed. Estimates from the Cox model were used to derive a score reflecting the risk of death. Patient experience was divided into three categories. Patients in AIDS Grade I had an average death rate of one per 10·1 years, compared with one per 2·8 years in AIDS Grade II and one per 1·1 years in AIDS Grade III. Similar rates were seen in an independent validation study on 1230 AIDS patients at different hospital.

Our grading system should be useful for patient management, clinical trial design, surveillance, and resource management.

References (27)

  • Jd Lundgren et al.

    Survival differences in European patients with AIDS, 1979-89

    BMJ

    (1994)
  • P. Bachetti et al.

    Survival patterns of the first 500 patients with AIDS in San Francisco

    J Infect Dis

    (1988)
  • G. Marasca et al.

    Length of survival of patients with acquired immune deficiency syndrome in the United Kingdom

    BMJ

    (1986)
  • Gf Lemp et al.

    Survival trends for patients with AIDS

    JAMA

    (1990)
  • Dl Hanson et al.

    Survival prognosis of HIV-infected patients

    J Acquir Immune Defic Syndr

    (1993)
  • Rd Moore et al.

    Zidovudine and the natural history of the acquired immunodeficiency syndrome

    N Engl J Med

    (1991)
  • Bj Turner et al.

    The AIDS-defining diagnosis and subsequent complications: a survival-based severity index

    J Acquir Immune Defic Syndr

    (1991)
  • Gd Mills et al.

    Relationship between CD4 lymphocyte count and AIDS mortality, 1986-1991

    AIDS

    (1993)
  • Jm Colford et al.

    Factors associated with survival in Human Immunodeficiency Virus-infected patients with very low CD4 counts

    Am J Epidemiol

    (1994)
  • Ss Ellenberg et al.

    Statistical issues arising in AIDS clinical trials

    J Am Stat Ass

    (1992)
  • J. Darbyshire et al.

    Clinical trials in HIV infection: current problems and future directions

    AIDS

    (1991)
  • Jd Neaton, D. Wentworth, F. Rhame, C. Hogan, the CPCRA, Is disease progression the optimal endpoint for AIDS clinical...
  • Ac Justice et al.

    A new prognostic staging system for the Acquired Immunodeficiency Syndrome

    N Engl J Med

    (1989)
  • Cited by (0)

    1

    Participants listed at the end of article

    View full text